MGX – metagenomi, inc. (US:NASDAQ)
Stock Stats
News
Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”
Metagenomi, Inc. (NASDAQ: MGX) had its price target raised by analysts at HC Wainwright from $7.00 to $14.00. They now have a "buy" rating on the stock.
Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting
Metagenomi, Inc. Class Action: Levi & Korsinsky Reminds Metagenomi Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 25, 2024 - MGX
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Metagenomi, Inc. (MGX) Shareholders
Form 8-K Metagenomi, Inc. For: Dec 09
Form 4 Metagenomi, Inc. For: Dec 05 Filed by: Wapnick Pamela
Form 8-K Metagenomi, Inc. For: Nov 13
Form 10-Q Metagenomi, Inc. For: Sep 30
Form SC 13G Metagenomi, Inc. Filed by: BAYER HEALTHCARE LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.